Influence of different stimulation treatments on oocyte characteristics and in-vitro fertilizing ability
- PMID: 2521865
- DOI: 10.1093/oxfordjournals.humrep.a136870
Influence of different stimulation treatments on oocyte characteristics and in-vitro fertilizing ability
Abstract
A retrospective analysis was performed in order to compare the number and quality of oocytes recovered in in-vitro fertilization cycles according to different protocols for ovarian stimulation. Treatments including a gonadotrophin-releasing hormone agonist (GnRHa), either decapeptyl or buserelin, were associated with the recovery of more oocytes (6.0-7.2%) than treatments without GnRHa (3.7-4.8%). However, the mean number of normal embryos per patient yielding oocyte(s) was comparable between cycles stimulated with or without GnRHa (2.4-2.7), except in those cycles programmed with norethisterone and gonadotrophins (1.7). There was no difference in the rates of immature or atretic oocytes between stimulation treatments. Following clomiphene and human menopausal gonadotrophin treatment there was a lower rate of fractured zona oocytes, higher rates of fertilization and normal growth of fertilized eggs than after any other treatment. The proportion of normal embryos per recovered oocyte was inversely related to the degree of ovarian response in most of the stimulation treatments. Most of the abnormal embryos contained more than two pronuclei in cycles without GnRHa administration and exhibited polynucleated blastomeres in cycles treated with buserelin or decapeptyl. In conclusion, the use of GnRHa and gonadotrophins for ovarian stimulation increased the mean number of recovered oocytes, but did not increase the mean number of embryos able to develop.
Similar articles
-
Embryo quality and uterine receptivity in in-vitro fertilization cycles with or without agonists of gonadotrophin-releasing hormone.Hum Reprod. 1989 Feb;4(2):198-201. doi: 10.1093/oxfordjournals.humrep.a136871. Hum Reprod. 1989. PMID: 2521866
-
Hormonal stimulation for in vitro fertilization: a comparison of fertilization rates and cytogenetic findings in unfertilized oocytes.J Assist Reprod Genet. 1992 Jun;9(3):254-8. doi: 10.1007/BF01203824. J Assist Reprod Genet. 1992. PMID: 1525457
-
Effects of gonadotrophin-releasing hormone agonists (GnRHa) on follicle and oocyte quality.Hum Reprod. 1993 Apr;8(4):511-8. doi: 10.1093/oxfordjournals.humrep.a138086. Hum Reprod. 1993. PMID: 8501176 Review.
-
Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.Cochrane Database Syst Rev. 2002;(3):CD002808. doi: 10.1002/14651858.CD002808. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2005 Jan 25;(1):CD002808. doi: 10.1002/14651858.CD002808.pub2 PMID: 12137658 Updated. Review.
-
Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.Cochrane Database Syst Rev. 2011 Aug 10;(8):CD006919. doi: 10.1002/14651858.CD006919.pub3. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2015 Nov 09;(11):CD006919. doi: 10.1002/14651858.CD006919.pub4 PMID: 21833958 Updated. Review.
Cited by
-
Effects of controlled ovarian hyperstimulation on oocyte quality in terms of the incidence of apoptotic granulosa cells.J Assist Reprod Genet. 2000 Nov;17(10):580-5. doi: 10.1023/a:1026439409584. J Assist Reprod Genet. 2000. PMID: 11209539 Free PMC article. Clinical Trial.
-
Cycle characteristics and outcome in relation to ovarian response during in vitro fertilization.J Assist Reprod Genet. 1993 Nov;10(8):504-12. doi: 10.1007/BF01204360. J Assist Reprod Genet. 1993. PMID: 8081087
-
Area under the curve for estradiol levels do not consistently reflect estradiol levels on the day of hCG administration in patients undergoing controlled ovarian hyperstimulation for IVF-ET.J Assist Reprod Genet. 2005 Feb;22(2):57-63. doi: 10.1007/s10815-005-1494-4. J Assist Reprod Genet. 2005. PMID: 15844730 Free PMC article.
-
A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program.J Assist Reprod Genet. 1993 Jan;10(1):15-20. doi: 10.1007/BF01204435. J Assist Reprod Genet. 1993. PMID: 8499674
-
Pituitary down-regulation using leuprolide for the intensive ovulation management of poor prognosis patients having in vitro fertilization (IVF)-related treatments.J In Vitro Fert Embryo Transf. 1989 Dec;6(6):345-52. doi: 10.1007/BF01138775. J In Vitro Fert Embryo Transf. 1989. PMID: 2517507
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
